(Q35353001)

7 August 2017

1 reference

title

Cardiotoxicity of vasodilators and positive inotropic/vasodilating drugs in dogs: an overview (English)

1 reference

7 August 2017

Dogterom P

1

1 reference

7 August 2017

Zbinden G

series ordinal

2

1 reference

7 August 2017

Reznik GK

series ordinal

3

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 January 1992

1 reference

Critical Reviews in Toxicology

7 August 2017

1 reference

7 August 2017

22

1 reference

7 August 2017

3-4

1 reference

7 August 2017

203-241

1 reference

The role of toxicology in drug research and development

7 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

The current status of attempts to predict species differences in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Extrapolation from animals to man: predictions, pitfalls and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Disposition of xenobiotics: species differences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Extrapolation of animal toxicity to humans: interspecies comparisons in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Species specificity in the metabolism of nabilone. Relationship between toxicity and metabolic routes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Comparative aspects of contraceptive steroids--effects observed in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

The propionic acids. Gastrointestinal toxicity in various species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Toxicity of (4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol)), probucol, in mice, rats, dogs and monkeys: demonstration of a species-specific phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

The role of pharmacological profiling in safety assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Part I Digitalis glycosides: Mechanisms and manifestations of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Cyclic AMP and mechanisms of vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Pharmacology of positive inotropic phosphodiesterase III inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Cardiovascular and biological effects of K+ channel openers, a class of drugs with vasorelaxant and cardioprotective properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Potassium channel openers and vascular smooth muscle relaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Potassium channel modulators: scientific applications and therapeutic promise

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Release of atrial natriuretic peptide from rat myocardium in vitro: effect of minoxidil-induced hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Positive inotropy contributes to the hemodynamic mechanism of action of flosequinan (BTS 49465) in the intact dog

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Pharmacological actions of APP 201-533, a novel cardiotonic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Pharmacological studies with SK&F 94120, a novel positive inotropic agent with vasodilator activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Hypotensive and vasodilator actions of SK&F 24260, a new dihydropyridine derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Renal function studies with propildazine alone and in combination with propranolol in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Clinical evaluation of a new antihypertensive vasodilating agent PR-G 138 Cl

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Tolmesoxide, a drug that lowers blood pressure by a direct relaxant effect on vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

UD-CG 115 ? a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Systemic haemodynamic actions of pimobendan (UD-CG 115 BS) and its O-demethylmetabolite UD-CG 212 Cl in the conscious pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Studies aimed at elucidating the mechanism of action of CI-914, a new cardiotonic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Hemodynamic, pharmacokinetic and clinical response to CI-930 in congestive heart failure due to ischemic or dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one]

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Divergent effects of propranolol and furosemide pretreatment on acute cardiomyopathy induced by minoxidil in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Characterization and pharmacological relevance of high affinity binding sites for [3H]LY186126, a cardiotonic phosphodiesterase inhibitor, in canine cardiac membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

The inotropic effects of UK 14,275, a phosphodiesterase inhibitor, in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

E-type prostaglandins but not iloprost inhibit platelet activating factor-induced generation of leukotriene B4 by human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Zardaverine as a selective inhibitor of phosphodiesterase isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Positive Inotropic Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Systemic and coronary haemodynamic effects of the new hypotensive drug L 6150

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

The effects of cyclosidimine, a peripheral vasodilator drug, on blood pressure and heart rate in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Haemodynamic changes in heart failure induced by a new vasodilator tolmesoxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Acute dose range study of milrinone in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Cardiovascular effects of cromakalim (BRL 34915) in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Sympathetic and parasympathetic components of reflex tachycardia induced by hypotension in conscious dogs with and without heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Hemodynamic activity of L 6150. Systemic and coronary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Preclinical Pharmacology of Ro 31–6930, a New Potassium Channel Opener

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Haemodynamic profile of an inhibitor of phosphodiesterase III, adibendan (BM 14.478): comparison with nitroprusside and dobutamine in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Toxicologic studies with the hypotensive agent minoxidil

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Acute cardiomyopathy induced by the vasodilating antihypertensive agent minoxidil

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Cardiovascular alterations in dogs treated with hydralazine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Cardiotoxicity of a new inotrope/vasodilator drug (SK&F 94120) in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Comparative cardiovascular toxicity in dogs given inotropic agents by continuous intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Assessment of the acute cardiotoxic potential of sodium nitroprusside infusions in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Pharmacological analysis of the tachycardia produced by histamine and specific H1- and H2-receptor agonists in anesthetized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

A comparative study of minoxidil-induced myocardial lesions in beagle dogs and miniature swine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

Review of cardiovascular findings in humans treated with minoxidil

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408449209145324

10.3109/10408449209145324

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference